Jupiter, Florida – Providence Medical Technology, a San Francisco Area medical device startup and Medvest Fund One portfolio company, has had a busy month. It announced today that two-year follow-up data on patients treated with its DTRAX Facet System will be presented at the annual meeting of the Congress of Neurological Surgeons in San Francisco, October 19-23. These data support the durable safety and efficacy of indirect decompression for the treatment of cervical radiculopathy when using the DTRAX Facet System.
This news follows closely on the heels of an announcement made earlier in the month during the North American Spine Society’s 28th annual meeting in New Orleans. During the meeting Providence Medical Technology announced U.S. market availability of its PMT Cervical Cage. The system brings indirect decompression and fusion to the market. PMT will execute a limited market release through the fourth quarter of 2013 followed by a full national launch starting in the first quarter of 2014.
Details regarding both announcements can be found here.
Providence Medical Technology is a privately held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market. For more information on Providence Medical Technology contact David Schummers at (415) 925-9376 or firstname.lastname@example.org
Medvest Fund One is an $8.0 million private equity fund targeting medical device and technology companies who are positioned for growth and share the Fund’s core values. The Fund is accepting subscriptions. For more information contact David Cash at (561) 459-3333 or email@example.com